From the Guidelines
The primary types of skin malignancy are basal cell carcinoma, squamous cell carcinoma, and melanoma, with basal cell carcinoma being the most common type, accounting for about 75% of skin cancers, as reported in 1.
Types of Skin Malignancy
The three main types of skin malignancy are:
- Basal cell carcinoma: the most common type, accounting for about 75% of skin cancers, and typically appears as a pearly or waxy bump, often on sun-exposed areas like the face and neck 1.
- Squamous cell carcinoma: the second most common type, presenting as a firm red nodule or a flat lesion with a scaly surface, usually developing on sun-exposed skin 1.
- Melanoma: though less common, is the most dangerous form of skin cancer as it can spread rapidly to other organs if not detected early, and often appears as a new or changing mole with asymmetry, irregular borders, varied colors, diameter larger than 6mm, or evolution in size, shape, or color (the ABCDE rule) 1.
Prevention and Detection
These malignancies primarily develop due to cumulative UV radiation exposure, which damages DNA in skin cells, leading to uncontrolled cell growth 1. Regular skin examinations, sun protection (including broad-spectrum sunscreen SPF 30+, protective clothing, and avoiding peak sun hours), and prompt medical attention for suspicious skin changes are essential preventive measures 1. It is crucial to prioritize prevention and early detection to reduce the risk of skin malignancy and improve outcomes, as highlighted in 1.
From the Research
Types of Skin Malignancy
The primary types of skin malignancy include:
Characteristics of Each Type
- Basal Cell Carcinoma (BCC):
- Squamous Cell Carcinoma (SCC):
- Melanoma:
Risk Factors and Associations
- Exposure to solar UV radiation is a predominant risk factor for NMSCs 2
- Skin type also plays a role, with a higher incidence of NMSCs among fairer-skinned individuals 2
- Immunocompromise can increase the risk of NMSCs 2
- BCC, SCC, and Melanoma have been associated with other non-cutaneous primary malignancies, including lip, oropharyngeal, and salivary gland cancer, as well as prostate, breast, and colorectal cancer 6